236 related articles for article (PubMed ID: 26053184)
21. Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells.
Price RS; Cavazos DA; De Angel RE; Hursting SD; deGraffenried LA
Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):135-43. PubMed ID: 22333686
[TBL] [Abstract][Full Text] [Related]
22. Body mass index and survival in patients with epithelial ovarian cancer.
Suh DH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Kang SB
J Obstet Gynaecol Res; 2012 Jan; 38(1):70-6. PubMed ID: 21827578
[TBL] [Abstract][Full Text] [Related]
23. Long‑term exposure to leptin enhances the growth of prostate cancer cells.
Noda T; Kikugawa T; Tanji N; Miura N; Asai S; Higashiyama S; Yokoyama M
Int J Oncol; 2015 Apr; 46(4):1535-42. PubMed ID: 25625287
[TBL] [Abstract][Full Text] [Related]
24. Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways.
Jaffe T; Schwartz B
Int J Cancer; 2008 Dec; 123(11):2543-56. PubMed ID: 18767036
[TBL] [Abstract][Full Text] [Related]
25. Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.
Tang W; Ren A; Xiao H; Sun H; Li B
Biomed Pharmacother; 2017 Jan; 85():248-255. PubMed ID: 27908706
[TBL] [Abstract][Full Text] [Related]
26. Role of CXCL12 in metastasis of human ovarian cancer.
Jiang YP; Wu XH; Xing HY; DU XY
Chin Med J (Engl); 2007 Jul; 120(14):1251-5. PubMed ID: 17697577
[TBL] [Abstract][Full Text] [Related]
27. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication.
Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS
Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793
[TBL] [Abstract][Full Text] [Related]
28. Functional role and prognostic significance of CD157 in ovarian carcinoma.
Ortolan E; Arisio R; Morone S; Bovino P; Lo-Buono N; Nacci G; Parrotta R; Katsaros D; Rapa I; Migliaretti G; Ferrero E; Volante M; Funaro A
J Natl Cancer Inst; 2010 Aug; 102(15):1160-77. PubMed ID: 20639476
[TBL] [Abstract][Full Text] [Related]
29. Leptin and HER-2 are associated with gastric cancer progression and prognosis of patients.
Geng Y; Wang J; Wang R; Wang K; Xu Y; Song G; Wu C; Yin Y
Biomed Pharmacother; 2012 Sep; 66(6):419-24. PubMed ID: 22883999
[TBL] [Abstract][Full Text] [Related]
30. Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer.
Yue H; Wang J; Chen R; Hou X; Li J; Lu X
BMC Cancer; 2019 Dec; 19(1):1266. PubMed ID: 31888563
[TBL] [Abstract][Full Text] [Related]
31. Activation of p70S6K induces expression of matrix metalloproteinase 9 associated with hepatocyte growth factor-mediated invasion in human ovarian cancer cells.
Zhou HY; Wong AS
Endocrinology; 2006 May; 147(5):2557-66. PubMed ID: 16469801
[TBL] [Abstract][Full Text] [Related]
32. Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation.
Long H; Xie R; Xiang T; Zhao Z; Lin S; Liang Z; Chen Z; Zhu B
Stem Cells; 2012 Oct; 30(10):2309-19. PubMed ID: 22887854
[TBL] [Abstract][Full Text] [Related]
33. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism.
Simopoulou T; Malizos KN; Iliopoulos D; Stefanou N; Papatheodorou L; Ioannou M; Tsezou A
Osteoarthritis Cartilage; 2007 Aug; 15(8):872-83. PubMed ID: 17350295
[TBL] [Abstract][Full Text] [Related]
35. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.
Kato S; Liberona MF; Cerda-Infante J; Sánchez M; Henríquez J; Bizama C; Bravo ML; Gonzalez P; Gejman R; Brañes J; García K; Ibañez C; Owen GI; Roa JC; Montecinos V; Cuello MA
Endocr Relat Cancer; 2018 Oct; 25(10):821-836. PubMed ID: 29848667
[TBL] [Abstract][Full Text] [Related]
36. Leptin-induced signaling pathways in cancer cell migration and invasion.
Ghasemi A; Saeidi J; Azimi-Nejad M; Hashemy SI
Cell Oncol (Dordr); 2019 Jun; 42(3):243-260. PubMed ID: 30877623
[TBL] [Abstract][Full Text] [Related]
37. Leptin enhances the invasive ability of glioma stem-like cells depending on leptin receptor expression.
Han G; Zhao W; Wang L; Yue Z; Zhao R; Li Y; Zhou X; Hu X; Liu J
Brain Res; 2014 Jan; 1543():1-8. PubMed ID: 24161825
[TBL] [Abstract][Full Text] [Related]
38. Leptin and its receptors in obese patients with colorectal cancer.
Stachowicz M; Mazurek U; Nowakowska-Zajdel E; Niedworok E; Fatyga E; Muc-Wierzgon M
J Biol Regul Homeost Agents; 2010; 24(3):287-95. PubMed ID: 20846476
[TBL] [Abstract][Full Text] [Related]
39. Leptin, obesity and breast cancer: progress to understanding the molecular connections.
Barone I; Giordano C; Bonofiglio D; Andò S; Catalano S
Curr Opin Pharmacol; 2016 Dec; 31():83-89. PubMed ID: 27816025
[TBL] [Abstract][Full Text] [Related]
40. Impact of body mass index on ovarian cancer survival varies by stage.
Bandera EV; Lee VS; Qin B; Rodriguez-Rodriguez L; Powell CB; Kushi LH
Br J Cancer; 2017 Jul; 117(2):282-289. PubMed ID: 28588323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
